Answer
People without previous EBV exposure have a higher risk of post-transplant lymphoproliferative disorder. Belatacept must not be given when EBV testing is negative or the status is unknown.
Sources for this answer
- NULOJIX 250 mg powder for concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 17